Crossing the Blood-Brain Barrier with Antibody-Labeled, Gold-Coated Nanoconjugates: A Preliminary Step in Targeting and Eradicating Brain Tumors
This paper shows ultrastructural proof of principle that antibodylabeled nanoconjugates can cross the blood-brain barrier and bind to their targeted antigens. Gold-coated nanoconjugates labeled with monoclonal…

